Alex Jia-Hong Lin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Top Venues

Annals of hematology

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 103 (6) (2024)
Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology (2024)
Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 103 (6) (2024)
Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 103 (6) (2024)
Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An Hou
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 103 (6) (2024)
Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, Ming-Sun Yu, Shih-Hao Huang, Alex Jia-Hong Lin, Kuan-Der Lee, Min-Chi Chen
Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study. Therapeutic advances in hematology 14 (2023)
Tsung-Hsien Tsai, Lennex Hsueh-Lin Yu, Ming-Sun Yu, Shih-Hao Huang, Alex Jia-Hong Lin, Kuan-Der Lee, Min-Chi Chen
Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study. Therapeutic advances in hematology 14 (2023)